SWS Hemodialysis Care Co., Ltd. (SHA:688410)
China
· Delayed Price · Currency is CNY 15.23
-0.19 (-1.23%)
At close: Mar 9, 2026
SWS Hemodialysis Care Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 806.82 | 567.1 | 689.96 | 381.89 | 283.1 | Upgrade
|
| Other Revenue | - | 0.18 | 0.15 | 0.12 | 0.17 | Upgrade
|
| Revenue | 806.82 | 567.27 | 690.11 | 382.01 | 283.28 | Upgrade
|
| Revenue Growth (YoY) | 42.23% | -17.80% | 80.65% | 34.86% | 11.35% | Upgrade
|
| Cost of Revenue | - | 320.46 | 354.38 | 217.09 | 168.83 | Upgrade
|
| Gross Profit | 806.82 | 246.81 | 335.73 | 164.93 | 114.44 | Upgrade
|
| Selling, General & Admin | - | 157.6 | 132.21 | 97.7 | 80.34 | Upgrade
|
| Research & Development | - | 54.24 | 37.67 | 23.13 | 17.74 | Upgrade
|
| Other Operating Expenses | 623.23 | 4.55 | -17.35 | -8.68 | -4.77 | Upgrade
|
| Operating Expenses | 623.23 | 214.65 | 155.93 | 115.29 | 95.22 | Upgrade
|
| Operating Income | 183.6 | 32.16 | 179.8 | 49.64 | 19.23 | Upgrade
|
| Interest Expense | - | -0.28 | -0.16 | -0.8 | -1.61 | Upgrade
|
| Interest & Investment Income | - | 25.56 | 25.72 | 2.61 | 4.8 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.93 | 0.68 | 0.74 | -0.2 | Upgrade
|
| Other Non Operating Income (Expenses) | -20.1 | -0.58 | 2.67 | -1.05 | -0.74 | Upgrade
|
| EBT Excluding Unusual Items | 163.49 | 57.79 | 208.71 | 51.14 | 21.48 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 9.14 | 10.79 | 0.78 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.28 | 0.45 | -0.34 | 0.04 | Upgrade
|
| Asset Writedown | - | -8.01 | - | - | -0.05 | Upgrade
|
| Other Unusual Items | - | 9.78 | - | 11.77 | 0.59 | Upgrade
|
| Pretax Income | 163.49 | 68.42 | 219.95 | 63.36 | 22.05 | Upgrade
|
| Income Tax Expense | 20.38 | 4.42 | 27.74 | 6.46 | 3.91 | Upgrade
|
| Earnings From Continuing Operations | 143.12 | 64 | 192.21 | 56.9 | 18.14 | Upgrade
|
| Minority Interest in Earnings | - | 6.89 | 2.29 | 2.33 | 1.33 | Upgrade
|
| Net Income | 143.12 | 70.89 | 194.5 | 59.24 | 19.47 | Upgrade
|
| Net Income to Common | 143.12 | 70.89 | 194.5 | 59.24 | 19.47 | Upgrade
|
| Net Income Growth | 101.89% | -63.55% | 228.34% | 204.20% | -5.55% | Upgrade
|
| Shares Outstanding (Basic) | 321 | 320 | 321 | 321 | 241 | Upgrade
|
| Shares Outstanding (Diluted) | 321 | 320 | 321 | 321 | 241 | Upgrade
|
| Shares Change (YoY) | 0.45% | -0.49% | 0.03% | 33.29% | 10.47% | Upgrade
|
| EPS (Basic) | 0.45 | 0.22 | 0.61 | 0.18 | 0.08 | Upgrade
|
| EPS (Diluted) | 0.45 | 0.22 | 0.61 | 0.18 | 0.08 | Upgrade
|
| EPS Growth | 100.99% | -63.37% | 228.25% | 128.22% | -14.50% | Upgrade
|
| Free Cash Flow | - | 59.97 | -47.97 | 232.9 | 4.69 | Upgrade
|
| Free Cash Flow Per Share | - | 0.19 | -0.15 | 0.72 | 0.02 | Upgrade
|
| Dividend Per Share | - | 0.100 | 0.269 | - | - | Upgrade
|
| Dividend Growth | - | -62.76% | - | - | - | Upgrade
|
| Gross Margin | 100.00% | 43.51% | 48.65% | 43.17% | 40.40% | Upgrade
|
| Operating Margin | 22.75% | 5.67% | 26.05% | 13.00% | 6.79% | Upgrade
|
| Profit Margin | 17.74% | 12.50% | 28.18% | 15.51% | 6.87% | Upgrade
|
| Free Cash Flow Margin | - | 10.57% | -6.95% | 60.97% | 1.65% | Upgrade
|
| EBITDA | 202.32 | 50.88 | 196.03 | 63.94 | 32.99 | Upgrade
|
| EBITDA Margin | 25.08% | 8.97% | 28.41% | 16.74% | 11.65% | Upgrade
|
| D&A For EBITDA | 18.73 | 18.73 | 16.23 | 14.3 | 13.76 | Upgrade
|
| EBIT | 183.6 | 32.16 | 179.8 | 49.64 | 19.23 | Upgrade
|
| EBIT Margin | 22.75% | 5.67% | 26.05% | 13.00% | 6.79% | Upgrade
|
| Effective Tax Rate | 12.46% | 6.46% | 12.61% | 10.19% | 17.72% | Upgrade
|
| Revenue as Reported | - | 567.27 | 690.11 | 382.01 | 283.28 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.